Nerve Block for Pediatric ENT Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a treatment called the Superficial Cervical Plexus Block, a type of nerve block, to determine if it reduces pain and the need for opiate painkillers after ear surgery in children. The study compares two groups: one receiving the nerve block with standard care and the other receiving a placebo with standard care. Suitable candidates for this trial include children undergoing a unilateral cochlear implant or tympanomastoidectomy, without recent opiate use or certain medical conditions. The goal is to determine if adding this nerve block improves pain management. As a Phase 4 trial, this research examines how an already FDA-approved and effective treatment can benefit more patients, potentially enhancing pain management strategies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you've used opiates in the last 30 days.
What is the safety track record for the Superficial Cervical Plexus Block?
Research has shown that the superficial cervical plexus block (SCPB) is generally safe and has few side effects. Rarely, it may cause temporary issues like Horner's syndrome, which leads to drooping eyelids and smaller pupils. One study found SCPB to be a low-risk anesthesia method, often used safely in head and neck surgeries. Overall, SCPB is well-tolerated in various procedures, making it a promising option for reducing pain in children's ear surgeries.12345
Why are researchers enthusiastic about this study treatment?
Researchers are excited about the Superficial Cervical Plexus Block for pediatric ENT surgery because it offers a non-opioid, targeted pain relief option. Unlike standard treatments that often rely on systemic pain relievers like opioids, this nerve block focuses on numbing specific nerves in the neck area, potentially reducing the need for more generalized pain medications. This method could minimize side effects and enhance recovery times, making it a promising alternative to traditional pain management approaches in children undergoing surgery.
What evidence suggests that the Superficial Cervical Plexus Block is effective for pediatric ear surgery?
Research has shown that a type of anesthesia called the superficial cervical plexus block (SCPB) can reduce pain for children undergoing ear surgeries. In this trial, some participants will receive SCPB, while others will receive a placebo. One study found that SCPB significantly lowered the need for strong painkillers like fentanyl and paracetamol during and after surgery. Another study demonstrated that SCPB provided longer-lasting pain relief after surgery compared to not using the block. While these findings are promising, most research has involved adults, with only a few cases involving children, indicating SCPB's potential to reduce pain and the need for medication during surgeries near the head and neck.24678
Who Is on the Research Team?
Benjamin Fuller, MD
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for children older than 3 months and under 18 years who are having specific ear surgeries (like cochlear implant or tympanomastoidectomy). They can't join if they've used opiates recently, have severe breathing issues, are allergic to ropivacaine, need bilateral surgery, don't have an English-speaking caregiver, refuse to participate, have bleeding disorders or infections at the injection site.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo surgery with or without the superficial cervical plexus block
Follow-up
Participants are monitored for safety and effectiveness after treatment, including opioid use and recovery quality
What Are the Treatments Tested in This Trial?
Interventions
- Superficial Cervical Plexus Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor